Pinellia pedatisecta agglutinin (PPA) is a specific mannose-binding plant lectin accumulated in the tuber of P. pedatisecta. In the work presented, the cytotoxicity of PPA to cancer cells was investigated through exogenous expression. A PPA gene was transduced into normal and cancer cell lines through plasmid vectors, and the effect of PPA expression was examined. Results showed that PPA translocated into the nucleus, colocalized with DNA and induced cell death. A mannose-binding motif and a V 103 -W 130 region directed the nuclear translocation of PPA. Coprecipitation, mass spectrometry and western blotting analysis further indentified that PPA was associated with the methylosome, which contains methylosome protein 50 and protein arginine methyltransferase 5 (PRMT5). Knockdown of PRMT5 significantly inhibited the PPA-induced cell death, suggesting that PPA used the methylosome as a target. Furthermore, Ad.surp-PPA, an adenovirus vector in which the PPA gene was controlled by a survivin promoter (surp), selectively inhibited the proliferation of cancer cell lines. Taken together, the expression of PPA gene elicited significant cytotoxicity to cancer cells through targeting the methylosome and might be developed into a novel agent in cancer gene therapy.
INTRODUCTION
Lectins are carbohydrate-binding proteins containing at least one non-catalytic domain that binds reversibly with mono-or oligosaccharide with high specificity and affinity. 1, 2 An increasing number of three-dimensional structures of lectins has been revealed, which has led to better understanding of the interaction between sugars and carbohydrate recognition domains in lectins. 3, 4 Carbohydrates are a highly diverse group because of their variability in saccharide monomers and complicating structures. Interestingly, the diversity of carbohydrate decoration in mammalian cell membranes and viral particles can be recognized by specific plant lectins, which are originally involved in plant defense and root symbiosis. [3] [4] [5] At present, plant lectins have been used in studies of mammalian cells and viruses, such as peanut agglutinin in identifying hematopoietic cell sub-populations, 6, 7 soybean agglutinin in preparation of proper cell fraction for bone marrow transplantation, 8 Galanthus nivalis agglutinin, hippeastrum hybrid agglutinin, cymbidium agglutinin and Urtica dioica agglutinin in targeting HIV, 9, 10 and a variety of plant lectins in providing markers and therapeutic agents for cancer cells. 11 Monocot mannose-binding lectins (MBLs) constitute a superfamily of mannose-specific lectins, which have mainly been isolated and cloned from families of Alliaceae, Amarylliadaceae, Orchidaceae, Liliaceae, Iridaceae and Araceae.
12,13
Pinellia pedatisecta agglutinin (PPA) is a mannose-binding lectin accumulated in the tuber of P. pedatisecta, an Araceae species. Based on the genomic and complementary DNA sequences of PPA reported previously, 14, 15 a recombinant PPA has been used in labeling fractions of myeloid leukemia cells in our laboratory. 16 In this work, a PPA gene was transfected into a variety of human cells including normal and cancer cell lines through plasmid vectors. The exogenous PPA expression and the underlying mechanism of PPA-induced cell death were investigated. To further evaluate the antiproliferative effect of the PPA gene, a replication-defective adenovirus harboring the PPA gene under the control of a survivin promoter (surp), Ad.surp-PPA, was constructed. The selective cytotoxicity of this adenovirus to cancer cells was analyzed as well.
RESULTS

Exogenous expression of PPA in normal and cancer cells
The amino-acid sequence of PPA was shown in Figure 1a . To determine the exogenous expression of PPA in human normal and cancer cells, pcDNA3.1/His-PPA or pcDNA3.1/His plasmids were transfected into a panel of cells and the expression of PPA was examined by western blotting analysis with an anti-6his antibody. Results showed that 6his-PPA with a molecular weight as expected was detected in normal lung cell line WI38, lung cancer cell lines A549, H460 and H1299 (Figure 1b) , as well as hepatocellular carcinoma cell lines PLC and Hep3B (Figure 1c) . To further determine the exogenous expression of PPA, lung cancer cell line H1299 was transfected with pcDNA3/FLAG-PPA or pcDNA3/FLAG plasmids followed by western blotting analysis with an anti-FLAG antibody. As compared with pcDNA3/FLAGtransfected cells, FLAG-PPA was detected in pcDNA3/FLAG-PPAtransfected cells (Figure 1d ). Our results indicate that PPA gene can be expressed in a variety of human cells including both normal and malignant cell lines.
PPA translocated into the nucleus and induced cell death We then examined the effect of PPA expression in both normal and cancer cells. Plasmids pEGFP-C1 or pEGFP-PPA-C1 were transfected into hepatocellular carcinoma cell lines Hep3B and Huh7, lung cancer cell line A549 and normal lung cell line WI38 followed by fluorescent microscope observation. As compared with pEGFP-C1 transfected cells, most of cells transfected with pEGFP-PPA-C1 exhibited a number of green fluorescence dots at the early stage (before 24 h). At the late stage (after 48 h), dots in majority of cells were finally accumulated in a central area, which can be stained by propidium iodide, a DNA staining agent for damaged cells. A condensation of DNA was also observed (Figure 2 ). Results suggested that PPA entered the nucleus and colocalized with DNA, which might subsequently alter the chromatin structure and induce cell death.
A mannose-binding motif and a V 103 -W 130 region directed the nuclear translocation of PPA The entrance of PPA into the nucleus suggested that there might exist a nuclear localization signal in PPA. As PPA is a specific mannose-binding lectin, we proposed that the mannose-binding motifs (MBMs) in PPA might have a role in nuclear translocation. To test this hypothesis, a sequence of MBM in PPA (QDNGFGVVY) indicated in Figure 1a was cloned into pEGFP-C1 plasmids to form pEGFP-MBM-C1. Plasmids pEGFP-MBM-C1 and pEGFP-C1 were then transfected into hepatocellular carcinoma cell lines PLC and Huh7, as well as lung-cancer cell line H1299. As observed under a fluorescence microscope, MBM obviously directed enhanced green fluorescent protein (EGFP) to translocate into the nucleus ( Figure 3a ). The nuclear localization of EGFP was further verified by a Hoechst33342 staining in H1299 cells (Figure 3b ). The intact morphology of the nucleus stained by Hoechst33342 shown in Figure 3b also suggested that MBM alone did not induce obvious cell damage. Our results indicated that the MBM was responsible for directing PPA to translocate into the nucleus.
To further investigate the localization pattern of PPA, a sequence encoding the V 103 -W 130 region without a predicted MBM was cloned into pEGFP-C1 to generate pEGFP-( V PPA-induced cell death through targeting the methylosome We then further investigated the underlying mechanism of the PPA-induced cell death through examining intracellular proteins interacting with PPA. H1299 cells were transfected with pcDNA3/ FLAG-PPA or pcDNA3/FLAG plasmids followed by immunoprecipitation with a FLAG antibody conjugated gel. A specific band in SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was subjected to mass spectrometry analysis, and the protein was identified as methylosome protein 50 (MEP50) ( Table 1) , a component of the methylosome. 24 To verify the association of PPA with the methylosome, anti-FLAG precipitated complexes were subjected to western blotting analysis. As shown in Figure 5a , both MEP50 and protein arginine methyltransferase 5 (PRMT5) were found to be associated with PPA, indicating the interaction of PPA with the methylosome.
To further elucidate the role of the methylosome in the PPA-induced cell death, H1299 cells were transfected with a control small interfering RNA (siRNA) or PRMT5 siRNA followed by a second transfection with pEGFP-PPA-C1. Results showed that the knockdown of PRMT5 expression significantly inhibited the accumulation and nuclear translocation of PPA in some cells, which was totally not observed in cells transfected with the control siRNA (Figure 5b ). The knockdown efficiency of PRMT5 was shown in Figure 5c . Taken together, our data indicated that PPA-induced cell death through using the methylosome as a target. Controlled expression of PPA elicited selective toxicity to cancer cells
To evaluate the antiproliferative effect of PPA gene against cancer cells, Ad.surp-PPA, a replication-defective adenovirus harboring the PPA gene under the control of a survivin promoter, was constructed. Previous studies have demonstrated that survivin is an apoptosis inhibitor highly expressed in most cancers and low expressed in terminally differentiated cells, 29 and the survivin promoter has been used as a cancer-specific promoter to control gene expression in generating oncolytic viruses. 30 Ad.surp-PPA was infected into normal lung cell line WI38, lung-cancer cell line H1299 and hepatocellular carcinoma cell lines Huh7 and PLC at multiplicity of infections indicated. Figure 6 showed that Ad.surp-PPA elicited a minimal toxicity to WI38. However, cell proliferation was significantly inhibited in H1299, Huh7 and PLC cells by Ad.surp-PPA at a dosage-dependent manner, and the maximum inhibition was achieved in PLC cells. Our data indicated that the cancer-specifically controlled expression of PPA elicited selective toxicity to cancer cells.
DISCUSSION
PPA is a mannose-binding lectin accumulated in the tuber of P. pedatisecta. In the work presented, the PPA gene was exogenously expressed in a variety of human normal and cancer cell lines. Results showed that PPA translocated into the nucleus, colocalized with DNA, and induced cell death through targeting the MEP50/ PRMT5 methylosome. A MBM in PPA and the V 103 -W 130 region directed the nuclear translocation of PPA. Furthermore, Ad.surp-PPA, a replication-defective adenovirus carrying a survivin promoter controlled PPA gene elicited a selective cytotoxicity to cancer cells, suggesting an antiproliferative effect of the PPA gene against cancer cells.
PRMT5 is a type II protein arginine methyltransferase, which catalyzes monomethylation and symmetric dimethylation of arginine residues.
17 PRMT5 methylates histones H2A, H3 and H4, [18] [19] [20] as well as non-histone proteins such as Sm proteins, which are essential for the formation of spliceosomal small nuclear ribonucleoproteins. 21 The diverse functions of PRMT5 are achieved through forming multiple complexes with a variety of proteins. For example, PRMT5 associated with SWI/SNF chromatin remodeling complexes methylates histone H3 arginine 8 and suppresses the expression of tumor repressor genes ST7 and NM23. 19 A complex containing PRMT5 and Blimp1 methylates histone H2A and H4R3, and regulates germ cell development. 22 Kruppel-like zinc finger protein ZNF224 forms a transcriptional repressor complex with PRMT5 and suppresses aldolase A gene expression. 23 The methylosome containing PRMT5 and MEP50 has been shown in methylating Sm proteins and histones. 24, 25 Recently, MEP50/ PRMT5 complex was shown in mediating the nuclear cyclin D1/ CDK4 kinase triggered neoplastic growth, suggesting an oncogenic role of PRMT5. 26 In our results, PPA was determined to be associated with both the MEP50/PRMT5 methylosome and DNA, as well as resulted in DNA coagulation, suggesting a role of PPA in connecting the methylosome to chromatin structure alteration. Therefore, investigations into chromatin modifications may help to further elucidate the PPA-induced cell death. Cancer gene therapy represents a strategy that genetic materials are delivered to specific cells or tissues to cause cancer cell death, stimulate immune cells or restore normal cellular phenotypes through viral, non-viral or cell vectors. 27, 28 In the work presented, a replication-defective adenovirus Ad.surp-PPA was constructed to deliver a survivin promoter controlled PPA gene into normal cells and cancer cells. As determined by others previously, survivin is an inhibitor of apoptosis overexpressed in a variety of cancer cells, 29 and the survivin promoter has been used to target various cancer cells. 30 As shown in our data, a selective cytotoxicity of Ad.surp-PPA to cancer cells was observed, suggesting that delivering PPA gene under cancer-specific control to malignant cells may be a useful strategy in cancer gene therapy. Thus, the PPA gene could be a novel anticancer gene in future cancer therapies.
In conclusion, our data indicate that exogenously expressed PPA in cancer cells translocated to the nucleus, colocalized with DNA, and induced cell death through acting on the methylosome as a target. A MBM and the V 103 -W 130 region directed the translocation of PPA. Using adenoviral vectors harboring PPA gene under cancer-specific control could be a novel method in cancer gene therapy. However, the underlying mechanism of the PPAinduced cell death is still not completely revealed. Further investigations may help to further elucidate the PPA-induced cell death and provide insights into utilizing the PPA gene in cancer gene therapy.
MATERIALS AND METHODS Plasmids
The plasmid pMD-18T-PPA containing full-length PPA genomic DNA sequence was constructed as described previously. 16 A sequence encoding 234 amino-acids of PPA flanked by EcoRV and XhoI sites was amplified by PCR from pMD-18T-PPA. The sense primer was 5 0 -TATGATATCGTGGGAA CCAACCACC TGCTGT-3 0 and the antisense primer was 5 0 -TATCTCGAGCTA CGCGGCAATTGG GCGCTTC-3 0 . The PCR product was inserted into the corresponding site of pcDNA3.1/His to generate the pcDNA3.1/His-PPA plasmid. The PPA sequence flanked by XhoI sites at both the ends was amplified from pMD-18T-PPA. The sense primer was 5 0 -TATCTCGAGTGGTG GGCACCAACTAC-3 0 and the antisense primer was 5 0 -TATCTCGAGCTACGCG GCAATTGGGCGCTTC-3 0 . The PCR product was inserted into the corresponding site of pEGFP-C1 to generate pEGFP-PPA-C1 plasmid. The PPA sequence flanked by EcoRI and XhoI sites was cut from pEGFP-PPA-C1 and inserted into pcDNA3/FLAG to generate pcDNA3/FLAG-PPA plasmid. A pair of complementary oligonucleotides encoding a PPA MBM with an amino acid sequence LQDNGFGVVYG were synthesized and annealed to form a DNA duplex. The annealed oligonucleotides contained EcoRI and XhoI sites at both the ends. The sequences of the oligonucleotides were 
Adenoviral construction
Human CMV promoter was deleted from the pCA13 plasmid to generate pCA13-nHCMV. A survivin promoter (surp) sequence flanked by SalI and EcoRI sites was inserted into pCA13-nHCMV to form pCA13-surp plasmid. A sequence encoding 6xHis and 234 amino acids of PPA flanked by SalI and EcoRI sites was amplified by PCR from pMD-18T-PPA and inserted into pCA13-surp to generate pCA13-surp-PPA. Plasmids pCA13-surp-PPA and pBHGE3 were cotransfected into HEK293 cells, and adenovirus Ad.surp-PPA was subsequently produced through homologous recombination. Viral titration was determined through serial dilution and infection in HEK293 cells. 
